J. B. Chemicals & Pharmaceuticals announces DJSI score of 77
This achievement underscores the company’s steadfast commitment to sustainability, corporate responsibility, and ESG excellence
This achievement underscores the company’s steadfast commitment to sustainability, corporate responsibility, and ESG excellence
The company will offer end-to-end services and solutions for the sector with a specific focus on sustainability
The company will showcase groundbreaking innovations from its Pharma and Nutrition divisions, highlighting key ingredients and formulations designed to support holistic well-being
Biocon’s subsidiary Biocon Biologics Limited, which also participated independently in the assessment for the first time, reported an S&P Global ESG Score of 53
EBITDA margins expand to 31.3%
The project is set to attract significant manufacturing investments of approximately Rs. 10,500 crore and is also projected to create around 1 lakh direct and indirect jobs
These initiatives will strengthen the company’s capital base, providing financial flexibility for future
40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs
India's bio economy has experienced remarkable growth, skyrocketing from $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
The report also revealed that 87% of physicians agreed that FEE recommendations would help to improve the speed of recovery
Subscribe To Our Newsletter & Stay Updated